Common class of antidepressants may help with…Covid?

Dr. Jason Wilson discusses a recent, small randomized controlled trial published in JAMA which investigated the use of fluvoxamine, an SSRI, as a therapeutic treatment option for Covid. The results of the study and the proposed mechanism are quite interesting. Find out why fluvoxamine is not ready for prime time, but SSRIs may deserve funding for larger clinical studies.

Read More